Cytokinetics Inc. (CYTK)

NASDAQ

$61.65

$-1.14

(-1.82%)

After-Hours

Cytokinetics Inc. (CYTK) Live Price Chart

Last updated: ⁦2026-10-13 21:57:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Cytokinetics Inc. (CYTK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $61.65, with a market capitalisation of $8.75B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $54.30 to $88.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.75B
Open	$62.32
Day's High	$110.25
Day's Low	$3.05
Previous Close	$62.79
Volume	1.56M
Average Volume	1.96M
P/E Ratio	--
52-Week High	$88.31
52-Week Low	$54.30
Dividend Yield	--
Earnings Date	--

Cytokinetics Inc. (CYTK) After-Hours Stock Price

Cytokinetics Inc. (CYTK) is trading at $62.48 in after-hours trading as of 2026-10-13 21:54:00, down 0.50% ($0.31) from the regular-session close of $62.79.

After-hours trading shows how investors are pricing CYTK after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Cytokinetics Inc. (CYTK) 7-Day Stock Price Change

Over the past seven days, Cytokinetics Inc. (CYTK) moved from $65.60 to $61.65, representing a decline of 6.02% ($3.95).

The stock traded between $59.79 and $66.91 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.35 million shares, up versus the previous seven-day period, indicating higher trading activity.

CYTK 52-Week Price Position

Position in Range: 21.6%

52W Low$54.30

52W High$88.31

CYTK is currently trading at $61.65, placing it 21.6% of the way from its 52-week low of $54.30 to its 52-week high of $88.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cytokinetics Inc. (CYTK)?

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	673
Exchange	NASDAQ
Company Website	https://www.cytokinetics.com

How to Buy Cytokinetics Inc. (CYTK) Stock on MEXC

Eligible investors can buy real shares of Cytokinetics Inc. (CYTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CYTK and Place Your Order

Open the RealStocks trading page and search for CYTK. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cytokinetics Inc. (CYTK) stock price today?

Cytokinetics Inc. (CYTK) is currently trading at $ 61.65, down 1.81% ($1.14) from the previous close of $ 62.79. Intraday prices update in real time during regular trading hours.

2.Is CYTK stock going up or down today?

As of 2026-10-13 21:54:00, CYTK is trading at $ 61.65, down 1.81% ($1.14) from its previous close of $ 62.79. The stock has traded between $ 3.05 and $ 110.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is CYTK pre-market price?

As of 2026-10-13 21:54:00, CYTK is trading at $ 62.74 in pre-market trading, down 0.08% ($0.05) from the previous close of $ 62.79. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CYTK after-hours price?

As of 2026-10-13 21:54:00, CYTK is trading at $ 62.48 in after-hours trading, down 0.50% ($0.31) from the regular-session close of $ 62.79. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CYTK stock trading now?

CYTK trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CYTK sit relative to its 52-week high and low?

Over the past 52 weeks, CYTK has traded between a low of $ 54.30 and a high of $ 88.31. At $ 61.65, the stock is positioned 21.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cytokinetics Inc. in?

Cytokinetics Inc. (CYTK) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cytokinetics Inc.'s market capitalisation and where is it listed?

Cytokinetics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 8.75B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CYTK valued in terms of P/E ratio and EPS?

CYTK trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -6.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cytokinetics Inc. pay a dividend?

Cytokinetics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.